Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2016-10-31
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the intervention condition, patients with left-sided neglect receive intense training, including reading and visual spatial task with standardized and adapted visual cueing by the therapist. Improvements in reading and visual spatial tasks lead to a reduction of cues by the therapist. Accordingly, the patient has to apply self-cueing over time in order to solve the task.
For the control condition, all patients receive unspecific treatment without any standardized adapted cueing implemented by the therapist.
To enhance the effectivity of cueing in reading and visual spatial tasks, the investigators additionally conduct parietal transcranial direct current stimulation (tDCS) in those patients without tDCS exclusion criteria (see exclusion criteria below).
It is hypothesised that systematic and adaptive therapeutic cueing leads to a significant reduction of omissions of word and word parts in reading.
UPDATE: No Add-on tDCS was performed since it was not applicable for our severly impaired patients due to the strict exclusion criteria of tDCS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Musical Neglect Training for Patients With Visual Neglect
NCT03516825
Assessment and Training Visio Spatial Neglect in a Virtual Reality Environment
NCT02258789
A Model to Identify Specific Predictors of Spatial Neglect Recovery
NCT00990353
Oculomotor Training Improves Reading Eye Movement
NCT02981875
RECOGNeyes Gaze-Control Training
NCT06691646
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
* adaptive, therapeutic cueing during reading tasks
* adaptive, therapeutic cueing during visuo spatial tasks
Cueing
Control
\- unspecific neglect treatment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cueing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capacity of at least 30 minutes
* Ability to read in German language
* Mobilization of 80%
Exclusion Criteria
* Normal pressure hydrocephalus
* Shunt
* Craniectomy
* Epilepsy
* Other metal implants
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinikum Bremen Ost
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nergiz Turgut
MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helmut Hildebrandt, Prof. Dr.
Role: STUDY_DIRECTOR
Universität Oldenburg, Klinikum Bremen-Ost
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Bremen-Ost
Bremen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
367915
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.